SARS CoV-2 link to Parkinson's, N protein α-synuclein interaction

In summary, the studies found that Covid's 19 protein can speed up the aggregation process of α-synuclein, which may lead to Parkinson's disease.
  • #1
artis
1,481
976
While researching S protein interactions I stumbled across a couple of recent papers studying the increased risk of developing Parkinson's after a Covid infection and the possible mechanism that plays a role there.
https://pubmed.ncbi.nlm.nih.gov/34860005/
here is the full version of the study in the link above
https://pubs.acs.org/doi/10.1021/acschemneuro.1c00666#.
We show, in test tube experiments, that SARS-CoV-2 spike protein (S-protein) has no effect on α-synuclein aggregation, while SARS-CoV-2 nucleocapsid protein (N-protein) considerably speeds up the aggregation process. We observe the formation of multiprotein complexes and eventually amyloid fibrils. Microinjection of N-protein in SH-SY5Y cells disturbed the α-synuclein proteostasis and increased cell death. Our results point toward direct interactions between the N-protein of SARS-CoV-2 and α-synuclein as molecular basis for the observed correlation between SARS-CoV-2 infections and Parkinsonism.
Neurodegenerative diseases such as Alzheimer’s disease (AD) and PD are protein aggregation diseases in which specific proteins, tau and Aβ peptide in AD and α-synuclein (αS) in PD, assemble into amyloid aggregates. Once started, the aggregation process spreads from cell to cell and the formed aggregates and deposits hamper brain function
In the absence of additional proteins, the onset of aggregation of αS is observed at time scales >240 h,In the presence of N-protein, we see a strong decrease in the time to the onset of aggregation which reduces to <24 h

The N-protein is also considered as a target for vaccine development because in the SARS family of viruses, the N-protein gene is more conserved and stable than the S-protein gene
Well I guess no more...

Our results point toward a direct interaction between the N-protein of SARS-CoV-2 and αS as a molecular basis for the observed relations between virus infections and Parkinsonism. The observed molecular interactions thus suggest that SARS-CoV-2 infections may have long-term implications and that caution is required in considering N-protein as an alternative target in vaccination strategies.

https://parkinsonsnewstoday.com/202...-alpha-synuclein-buildup-parkinsons-hallmark/

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8150712/
 
  • Like
  • Informative
Likes Fervent Freyja, Tom.G, Oldman too and 3 others
Biology news on Phys.org
  • #2
@artis, I think that your post presents a grim report, and that nevertheless it's a likeworthy post.
 
  • Like
Likes Oldman too and artis

FAQ: SARS CoV-2 link to Parkinson's, N protein α-synuclein interaction

What is the link between SARS CoV-2 and Parkinson's disease?

Recent studies have found a potential link between SARS CoV-2, the virus that causes COVID-19, and Parkinson's disease. This link is due to the virus's ability to interact with a protein called α-synuclein, which is also involved in Parkinson's disease.

How does the interaction between SARS CoV-2 and α-synuclein contribute to Parkinson's disease?

The interaction between SARS CoV-2 and α-synuclein may lead to an increase in the production and accumulation of α-synuclein in the brain. This can contribute to the development of Parkinson's disease, as α-synuclein is known to form clumps in the brains of Parkinson's patients.

Is there evidence to support this link between SARS CoV-2 and Parkinson's disease?

While the link is still being studied, there is growing evidence to support the connection between SARS CoV-2 and Parkinson's disease. Multiple studies have found an increase in α-synuclein levels in COVID-19 patients, and autopsies have shown the presence of α-synuclein in the brains of COVID-19 patients who did not have Parkinson's disease prior to infection.

Can SARS CoV-2 directly cause Parkinson's disease?

At this time, there is no conclusive evidence that SARS CoV-2 can directly cause Parkinson's disease. However, the virus may contribute to the development or progression of the disease through its interaction with α-synuclein.

What implications does this link between SARS CoV-2 and Parkinson's disease have for COVID-19 patients?

If the link between SARS CoV-2 and Parkinson's disease is confirmed, it could have significant implications for COVID-19 patients. It may be important for these patients to be monitored for Parkinson's disease symptoms and receive appropriate treatment if necessary. Further research is needed to fully understand the impact of this link on COVID-19 patients.

Similar threads

Replies
97
Views
7K
Replies
2
Views
944
Replies
93
Views
16K
Replies
1
Views
987
Replies
31
Views
6K
Replies
14
Views
2K
Replies
1
Views
1K
Back
Top